Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
The product is expected to be launched in Q3FY25
The product is expected to be launched in Q3FY25
The inspection conducted by EDQM at its Visakhapatnam facility
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Subscribe To Our Newsletter & Stay Updated